Sax Wealth Advisors LLC Grows Position in Mettler-Toledo International, Inc. $MTD

Sax Wealth Advisors LLC boosted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 2.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 372 shares of the medical instruments supplier’s stock after acquiring an additional 10 shares during the quarter. Sax Wealth Advisors LLC’s holdings in Mettler-Toledo International were worth $437,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the business. Shell Asset Management Co. raised its position in Mettler-Toledo International by 120.7% in the second quarter. Shell Asset Management Co. now owns 1,309 shares of the medical instruments supplier’s stock worth $1,538,000 after acquiring an additional 716 shares in the last quarter. Slow Capital Inc. increased its position in shares of Mettler-Toledo International by 5.4% in the second quarter. Slow Capital Inc. now owns 4,469 shares of the medical instruments supplier’s stock valued at $5,249,000 after buying an additional 229 shares in the last quarter. Valeo Financial Advisors LLC purchased a new position in shares of Mettler-Toledo International in the second quarter valued at $234,000. Impact Investors Inc increased its position in shares of Mettler-Toledo International by 11.0% in the second quarter. Impact Investors Inc now owns 313 shares of the medical instruments supplier’s stock valued at $368,000 after buying an additional 31 shares in the last quarter. Finally, Abundance Wealth Counselors increased its position in shares of Mettler-Toledo International by 2.3% in the second quarter. Abundance Wealth Counselors now owns 753 shares of the medical instruments supplier’s stock valued at $896,000 after buying an additional 17 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Wall Street Analyst Weigh In

MTD has been the subject of a number of research analyst reports. Citigroup raised their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Thursday, August 21st. Bank of America increased their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Robert W. Baird increased their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Evercore ISI increased their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday. Finally, Barclays increased their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average price target of $1,336.50.

Mettler-Toledo International Trading Down 1.5%

Shares of NYSE:MTD opened at $1,307.98 on Friday. The stock’s 50-day moving average price is $1,277.46 and its two-hundred day moving average price is $1,189.50. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,486.76. The firm has a market cap of $26.94 billion, a price-to-earnings ratio of 33.12, a PEG ratio of 3.99 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the company earned $9.65 EPS. The firm’s quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 165 shares of the firm’s stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider directly owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock worth $2,371,208 in the last three months. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.